FDA provides new guidance on conducting clinical trials with decentralised elements
Clinical studies have traditionally required participants to come to [...]
Rare Conversations podcast: the future of the rare disease landscape with Simon Estcourt
In this podcast, the first in our Rare Conversations [...]
How to get an EMA marketing authorisation
Obtaining marketing authorisation in Europe can be a complex [...]
Getting an orphan drug marketing authorisation in the European Union
Thanks to its large population and well-established healthcare system, [...]
Revised Declaration of Helsinki adopted by the global medical community
The principles of Good Clinical Practice (GCP) are derived [...]
CDER releases annual ‘Accelerating Rare Disease Cures (ARC) Program’ report for 2024
The FDA’s Center For Drug Evaluation and Research (CDER) [...]
Why TMC is more than just a CRO
What is a clinical research organisation? By definition, a [...]
The role of pharmacovigilance in oncology drug trials
Some of our experts recently penned a thought-provoking article [...]
16th Annual Outsourcing in Clinical Trials East Coast 2025
This two-day event involves panel discussion and face-to-face networking [...]
12th Annual Clinical Trials in Oncology West Coast 2025
In its 12th year, this event is expanding with [...]